We recently completed a detailed assessment of lung fluid samples from 86 patients with COVID-19 and 254 patients with pneumonia from other causes. This analysis suggested specific mechanisms by which SARS-CoV-2 causes severe disease in some patients and identified possible strategies to target these mechanisms, which we test in this application.
|Effective start/end date||4/1/22 → 3/31/26|
- National Heart, Lung, and Blood Institute (5R01HL158139-02)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.